Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
mean decrease » a decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
ms decrease » _ decrease (Expand Search), a decrease (Expand Search), use decreased (Expand Search)
a fold » 5 fold (Expand Search), _ fold (Expand Search), 2 fold (Expand Search)
5 nn » 5 non (Expand Search), 59 nn (Expand Search), 5 nm (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
mean decrease » a decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
ms decrease » _ decrease (Expand Search), a decrease (Expand Search), use decreased (Expand Search)
a fold » 5 fold (Expand Search), _ fold (Expand Search), 2 fold (Expand Search)
5 nn » 5 non (Expand Search), 59 nn (Expand Search), 5 nm (Expand Search)
-
161
Unit cost per test type and per health facility for diagnosis of SARS-CoV-2 by Ag-RDT and RT-PCR.
Published 2023Subjects: -
162
-
163
-
164
-
165
2D-PAGE images and Venn diagram showing differential protein expression (>2-fold) between CON and HFX (A-D).
Published 2022“…The images of the 2D-PAGE show an increase of 43 spots (B) and a decrease of 17 spots (C) among the 268 paired spots in HFD compared to CON. …”
-
166
2D-PAGE images and Venn diagram showing differential protein expression (>2-fold) between HFD and HFX (A-D).
Published 2022“…The images of the 2D-PAGE show an increase of 35 spots (B) and a decrease of 8 spots (C) among the 264 paired spots in HFD compared to CON. …”
-
167
-
168
-
169
Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T...
Published 2022“…Specifically, compound <b>20g</b> displayed a 3.67-fold decrease of plasma AUC<sub>(tofacitinib, 0–∞)</sub> and a 9.61-fold increase of colonic AUC<sub>(tofacitinib, 0–12h)</sub>, compared with tofacitinib at a molar equivalent oral dose. …”
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180